Exclusive Online Content
Pandion Therapeutics Announces $58-Million Financing to Advance Tissue-Specific Immune Modulator Drugs
Pandion Therapeutics, Inc. recently announced the completion of a $58-million Series A financing. This funding will be used to advance its initial drug programs for…
Sanofi & Alnylam Enter Into Strategic Restructuring of RNAi Therapeutics Rare Disease Alliance
Sanofi and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today a strategic restructuring of their RNAi therapeutics alliance to streamline and…
Enable Injections Achieves ISO Certification to Meet Mounting Demand for Drug Delivery Device Combination Products
Enable Injections, Inc., developer of the advanced enFuse large volume wearable injectors (LVWI) platform for subcutaneous delivery of biologics, has been awarded the International Organization…
Secondary Packaging – How “One-Stop-Shop” Solutions Can Help Address a Changing World
By: Daniela Geiger, Vetter, Product & Service Manager In a rapidly aging world, it could be difficult for today’s pharmaceutical and biotechnology companies to…
Platform Technology Company Cell Design Labs to be Acquired by Gilead
Cell Design Labs, Inc. recently announced that Gilead Sciences has agreed to acquire them in a structured buy out valued for up to $567 million,…
Do's & Don'ts for Orphan Drug Support Programs
Getting personal with rare disease patients. By: Nancy Pilcher, RN, Director, Business Development, AmerisourceBergen Complex. It’s the word most often associated with the…
Vaccinex & Catalent Biologics to Collaborate on Antibody-Drug Conjugate Development
Catalent Pharma Solutions and Vaccinex, Inc. recently announced an agreement to develop an antibody-drug conjugate (ADC) using Catalent’s proprietary SMARTag® conjugation platform and GPEx® cell…
Navitas Brings End-to-End R&D Solutions to the Generic Drug Industry
Navitas Life Sciences, a TAKE Solutions Enterprise, provides services and technology to deliver "first-to-file" results to generic drug companies around the globe, allowing them to…
G1 Therapeutics & AstraZeneca Enter Clinical Trial Collaboration
G1 Therapeutics, Inc. recently announced a clinical trial collaboration with AstraZeneca to evaluate AstraZeneca’s epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) Tagrisso (osimertinib)…
Aptevo Therapeutics Announces Plans to Conduct Phase 2 Study
Aptevo Therapeutics Inc. recently announced recent developments related to the Company’s novel ADAPTIR bispecific antibody platform, including the planned commencement of a Phase 2 clinical…
Cesca Therapeutics Announces Issuance of Second Cellular Processing Patent Surrounding Company’s X-BACS Technology
Cesca Therapeutics Inc. recently announced that on November 21, 2017, the USPTO awarded the company a new US Patent No. 9,821,111 (the ‘111 patent), entitled…
Flexicare Acquires Medisize B.V.
Flexicare (Group) Limited, a leading UK headquartered manufacturer of medical devices, recently announced it has acquired Medisize B.V. from an affiliate of Phillips-Medisize, LLC. …
Quotient Sciences Acquires Pharmaterials, Launches as New Global Identity for Quotient Clinical
Quotient Sciences, the drug development services organization, recently announced it has acquired Pharmaterials, a contract development and manufacturing organization (CDMO) based in Reading, UK. The…
West Announces Official Opening of Expanded Kiefernweg Campus & New Center of Excellence for Innovation & Technology
West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, officially opened the Company’s recently expanded Kiefernweg Campus in Eschweiler, Germany,…
AC Immune SA to Receive Milestone Payment
AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical stage biopharmaceutical company with a broad pipeline focused on neurodegenerative diseases, recently announced that Genentech, a member…
Evonik & Eli Lilly Announce Renewal of a Long-Term Agreement
Evonik Industries and Eli Lilly and Company (Lilly) today announced the renewal of a long-term agreement under which Evonik will supply active pharmaceutical ingredients (APIs)…
Vetter to Expand its Secondary Packaging Service Capacity to Meet Rising Demands
Vetter, a global leader in prefilled drug delivery systems and an expert in complex packaging projects, recently announced a major expansion of its secondary packaging capacities…
Arcturus Therapeutics Announces Strategic Collaboration With J&J Innovation to Discover & Develop RNA Medicines
Arcturus Therapeutics, Inc., a leading RNA medicines company, recently announced today it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals,…
White Paper: Establishing cGMP Manufacturing Capability for Phase 1 Sterile, Dispersed, Injectable Dosage Forms
As a product transitions from pre-clinical development to a clinical development phase, the manufacturing process takes on a much greater role in the overall success…
AMRI Launches Stand-Alone Service; Expanding Solutions for Impurity Analysis & Toxicology Risk Assessment
AMRI, a global contract research, development and manufacturing organization that partners with the pharmaceutical and biotechnology industries to improve patient outcomes and quality of life,…
